viewCreso Pharma Ltd

Creso Pharma secures first retail order from Nova Scotia provincial government’s distributor NLSC

Mernova’s retail cannabis brand ‘Ritual Green’ will be launched and sold through the NSLC’s stores and e-commerce platform while retail sales through other province stores and online platforms may follow.

Creso Pharma Ltd - Creso Pharma secures first retail order from Nova Scotia provincial government’s distributor NLSC
Premium strains Lemon Haze (above) and HPG13 will be available through NSLC

Creso Pharma Ltd’s (ASX:CPH) (FRA:1X8) wholly-owned subsidiary Mernova Medicinal Inc has received an initial purchase order (PO) worth C$180,000 from the Nova Scotia Liquor Corporation in Canada for two of its premium strains, HPG13 and Lemon Haze.  

This milestone marks the imminent launch of Mernova’s Ritual Green brand of high-quality cannabis products into Canada’s rapidly growing recreational markets.

The NSLC is operated by the Nova Scotia Provincial government and is the sole distributor of retail cannabis in the province of Nova Scotia while Mernova is a licensed producer in the province.

Entering Canada’s retail markets diversifies Mernova’s revenue streams and builds on an established and growing wholesale product sales pipeline. 

Ramping up production

Mernova managing director Jack Yu said: “Receiving this initial PO is the first step to Mernova establishing itself as a trusted supplier of high-quality, locally grown, artisanal cannabis products to the NSLC. 

“To meet the supply chain demands of the NSLC and other provincial purchasers, we are adjusting our grow scheduling, while simultaneously ramping up production of our highest quality strains.

“We plan on taking full advantage of this opportunity to build our brand and brand loyalty, in our home province of Nova Scotia and I look forward to providing further updates in the near-term.” 

Launch of Ritual Green  

Ritual Green HPG13.

Mernova’s retail recreational cannabis products will be launched under the brand name ‘Ritual Green’ and will initially be sold through the NSLC’s stores and e-commerce platform.

The first product available to recreational customers will be Mernova’s high-quality dried flower in its natural form.

Additional high-quality products will be added to the product line as they become available.   

Creso Pharma said retail sales through other provinces’ stores and online platforms may follow.

Expansion opportunities 

Creso Pharma will continue to provide regular updates on both retail and wholesale sales and on additional expansion opportunities available to Mernova across both the recreational and medicinal cannabis markets.

Mernova is also making considerable progress towards securing EU Good Manufacturing Practice (GMP) certification and further updates will be provided as this process advances.

Quick facts: Creso Pharma Ltd

Price: 0.24 AUD

Market: ASX
Market Cap: $218.95 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Creso Pharma Ltd named herein, including the promotion by the Company of Creso Pharma Ltd in any Content on the Site, the Company receives from...


Creso Pharma subsidiary Mernova granted sales license from Health Canada

Creso Pharma (ASX:CPH) subsidiary Mernova managing director Jack Yu and vice president Isaac Allen joined Steve Darling from Proactive to discuss the granting of their sales license from Health Canada and what it allows them to do. Isaac Allen tells Proactive they are gearing up sales...

on 11/6/20

2 min read